Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04CXX
|
||||
Former ID |
DNCL002120
|
||||
Drug Name |
GNKG-168
|
||||
Indication | Chronic lymphocytic leukaemia [ICD10:C91] | Phase 1 | [524153] | ||
Company |
SBI Biotech
|
||||
Target and Pathway | |||||
Target(s) | Toll-like receptor 9 | Target Info | Modulator | [550450] | |
NetPath Pathway | BCR Signaling Pathway | ||||
PANTHER Pathway | Toll receptor signaling pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.